The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ryzhova M.V.

FGBU "NII neĭrokhirurgii im. akad. N.N. Burdenko" RAMN, Moskva

Shishkina L.V.

Burdenko Neurosurgery Institute, Moscow, Russia

Molecular methods in diagnosis of poorly differentiated malignant brain tumors in children

Authors:

Ryzhova M.V., Shishkina L.V.

More about the authors

Journal: Burdenko's Journal of Neurosurgery. 2015;79(2): 10‑20

Read: 2638 times


To cite this article:

Ryzhova MV, Shishkina LV. Molecular methods in diagnosis of poorly differentiated malignant brain tumors in children. Burdenko's Journal of Neurosurgery. 2015;79(2):10‑20. (In Russ., In Engl.)
https://doi.org/10.17116/neiro201579210-20

Recommended articles:
Glymphatic system in health and disease: a narrative review. Burdenko's Journal of Neurosurgery. 2025;(4):112-118
Features of the stru­cture of uterine scars after cesa­rean section. Russian Journal of Human Reproduction. 2025;(5):75-83

References:

  1. Ryzhova M.V., Zheludkova O.G., Ozerov S.S. et al. Original article. On the classification of embryonal tumors of the central nervous system. An embryonal tumor with abundant neuropil and true rosettes: a case report and a literature review. Vopr neirokhir 2011; 75: 4: 25-33. In Russian.
  2. Ryzhova M.V., Zheludkova O.G., Shhishkina L.V. et al. Post-treatment neuroblastoma maturation to ganglionic cell tumor. Opukholi golovy i shei 2012; 3: 69-72. In Russian.
  3. Arita K., Sugiyama K., Sano T., Oka H. Atypical teratoid/rhabdoid tumour in sella turcica in an adult. Acta Neurochir (Wien) 2008; 150: 491-496.
  4. Behdad A., Perry A. Central nervous system primitive neuroectodermal tumors: a clinicopathologic and genetic study of 33 cases. Brain Pathology 2010; 20: 441-450. doi: 10.1111/j.1750-3639.2009.00314.x.
  5. Bernstein K. de A., Sethi R., Trofimov A. et al. Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol Biol Phys 2013; 86: 1: 114-120.
  6. Blaney S.M., Kocak M., Gajjar A. et al. Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors: a pediatric brain tumor consortium study (PBTC-001). J Neurooncol 2012. doi: 10.1007/s11060-012-0929-x.
  7. Burger P.C., Scheithauer B.W. Tumors of the Central Nervous System (AFIP atlas of tumor pathology, Series 4. Fascicle 7). Am Reg Pathol (Washington DC) 2007; 596 + xiv Pages.
  8. Buscariollo D.L., Park H.S., Roberts K.B., Yu J.B. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a surveillance, epidemiology, and end results analysis. Cancer 2011.
  9. Campen C.J., Dearlove J., Partap S. et al. Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors. J Neurooncol 2012; 110: 287-291. doi: 10.1007/s11060-012-0969-2.
  10. Chadarevian J.P. de, Montes J.L., O’Gorman A.M., Freeman C.R. Maturation of cerebellar neuroblastoma into ganglioneuroma with melanosis.
  11. Chakravarti A., Wang M., Robins H.I. et al. RTOG 0211: a phase 1/2 study of radiation therapy with concurrent geftinib for newly diagnosed glioblastoma patients. Int J Radiat Oncol Biol Phys 2013; 85: 5: 1206-1211.
  12. Chi S.N., Zimmerman M.A., Yao X. et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 2008; 27: 3: 385-389. doi: 10.1200/JCO.2008.18.7724.
  13. Chinnaiyan P., Won M., Wen P.Y. et al. RTOG 0913: a phase 1 study of daily Everolimus (RAD001) in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys 2013; 86: 5: 880-884.
  14. Chintagumpala M., Hassall T., Palmer S. et al. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET. Neuro-Oncology 2009; 11: 33-40. http://neuro-oncology.dukejournals.org doi: 10.1215/15228517-2008-079.
  15. D’cunja J., Shalaby T., Rivera P. et al. Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cells. Eur J Cancer 2007; 43: 1581-1589. doi: 10.1016/j.ejca.2007.03.003.
  16. Dufour C., Beaugrand A., Deley M.C. le et al. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system. Cancer 2011. doi: 10.1002/cncr.26684.
  17. Eberhart C.G., Brat D.J., Cohen K.J., Burger P.C. Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Develop Pathol 2000; 3: 346-352. doi: 10.1007/s100249910049.
  18. Ellison D., Love S. Neuropathology. A reference text of CNS pathology. 3rd ed. Elsevier Mosby 2013.
  19. Fouladi M., Blaney S.M., Poussaint T.Y. et al. Phase II study of Oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors. A Pediatric Brain Tumor Consortium Study. Cancer 2006; 107: 2291-2297. doi: 10.1002/cncr.22241.
  20. Friedman G.K., Spiller S.E., Harrison D.K. et al. Treatment of children with glioblastoma with conformal radiation, temozolomide, and bevacizumab as adjuncts to surgical resection. J Pediatr Hematol Oncol 2013; 35: 3: e123-126. doi: 10.1097/MPH.0b013e318282cd7f.
  21. Gandhi R., Babu R., Cummings T.J., Adamson C. Adult primitive neuroectodermal tumors: the prognostic value of supratentorial location. J Neurooncol 2013. doi: 10.1007/s11060-013-1163-x.
  22. Gessi M., Pfister S., Hans V.H. et al. Absence of chromosome 19q13.41 amplification in a case of atypical teratoid/rhabdoid tumor with ependymoblastic differentiation. Acta Neuropathol 2011; 121: 283-285. doi: 10.1007/s00401-010-0778-7.
  23. Han L., Qiu Y., Xie C. et al. Atypical teratoid/rhabdoid tumors in adult patients: CT and MR imaging features. AJNR 2011; 32: 103-108. doi: 10.3174/ajnr.A2361.
  24. Jimenez R.B., Sethi R., Depauw N. et al. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Int J Radiat Oncol Biol Phys 2013.
  25. Judkins A.R. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology. Adv Anat Pathol 2007; 14: 5: 335-339.
  26. Karremann M., Rausche U., Roth D. et al. Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma. Br J Cancer 2013; 1-8. doi: 10.1038/bjc.2013.404.
  27. Kleihues P., Louis D.N., Scheithauer B.W. et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61: 3: 215-225.
  28. Koral K., Gargan L., Bowers D.C. et al. Imaging characteristics of atypical teratoid–rhabdoid tumor in children compared with medulloblastoma. AJR 2008; 190: 809-814. doi: 10.2214/AJR.07.3069.
  29. Korshunov A., Remke M., Gessi M. et al. Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. Acta Neuropathol 2010.
  30. Korshunov A., Ryzhova M., Jones D. T. W. et al. LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol 2012; 124: 875-881.
  31. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K. (Eds.): WHO Classification of Tumours of the Central Nervous System. IARC (Lyon) 2007.
  32. Louis D.N., Ohgaki H., Wiestler O.D. et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109. doi: 10.1007/s00401-007-0243-4.
  33. Lutterbach J., Liegibel J., Koch D. et al. Atypical teratoid/rhabdoid tumors in adult patients: case report and review of the literature. J Neuro-Oncol 2001; 52: 49-56.
  34. Makuria A.T., Rushing E.J., McGrail K.M. et al. Atypical teratoid rhabdoid tumor (AT/RT) in adults: review of four cases. Neurooncol 2008; 88: 321-330. doi: 10.1007/s11060-008-9571-z.
  35. Miller R., Perry A. Glioblastoma: morphologic and molecular genetic diversity. Arch Pathol Lab Med 2007; 131: 397-406.
  36. Miller S., Rogers H.A., Lyon P. et al. Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma. Neuro-Oncol 2011; 13: 8: 866-879.
  37. Miller S., Ward J.H., Rogers H.A. et al. Loss of INI1 protein expression defines a subgroup of aggressive central nervous system primitive neuroectodermal tumours. Brain Pathol 2012.
  38. Murphy E.S., Merchant T.E., Wu S. et al. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors. Int J Radiat Oncol Biol Phys 2012; 83: 5: 655-660. doi: 10.1016/j.ijrobp.2012.01.061.
  39. Nobusawa S., Suzuki A., Nagaishi M. et al. Anaplastic ependymoma with ependymoblastic multilayered rosettes. Hum Pathol 2013; pii: S0046-8177(13)00140-8. doi: 10.1016/j.humpath.2013.03.012.
  40. Ogita S., Tokiwa K., Arizono N., Takahashi T. Neuroblastoma: incomplete differentiation on the way to maturation or morphological alteration resembling maturity? Oncology 1988; 45: 3: 148-152.
  41. Paulus W., Kleihues P. Genetic profiling of CNS tumors extends histological classification. Acta Neuropathol 2010; 120: 269-270.
  42. Perry A., Miller C.R., Gujrati M. et al. Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases. Brain Pathol 2009; 19: 81-90.
  43. Pfister S., Remke M., Castoldi M. et al. Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes. Acta Neuropathol 2008;
  44. Pfister S., Remke M., Toedt G. et al. Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas. Genes Chromos Cancer 2007; 46: 839-851.
  45. Picard D., Miller S., Hawkins C.E. et al. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol 2012; 13: 8: 838-848.
  46. Raisanen J., Hatanpaa K.J., Mickey B.E., White C.L. III. Atypical teratoid/rhabdoid tumor: cytology and differential diagnosis in adults. Diagn Cytopathol 2004; 31: 1: 60-63. doi: 10.1002/dc.20064.
  47. Rezanko T., Tunakan M., Kahraman A. et al. Primary rhabdoid tumor of the brain in an adult. Neuropathology 2006; 26: 57-61.
  48. Shonka N.A., Armstrong T.S., Prabhu S.S. et al. Atypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused review. J Clin Med Res 2011; 3: 2: 85-92. doi: 10.4021/jocmr535w.
  49. Solomón M.T., Selva J.C., Figueredo J. et al. Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial. BMC Cancer 2013 13: 299. http://www.biomedcentral.com/1471-2407/13/299.
  50. Song K.S., Phi J.H., Cho B-K. et al. Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 2010; 6: 145-149.
  51. Song X., Allen R.A., Dunn S.T. et al. Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma. Int J Clin Exp Pathol 2011; 4: 7: 651-660.
  52. Sufit A., Donson A.M., Birks D.K. et al. Diffuse intrinsic pontine tumors: a study of primitive neuroectodermal tumors versus the more common diffuse intrinsic pontine gliomas. J Neurosurg Pediatr 2012; 10: 81-88. http://thejns.org/doi/abs/10.3171/2012.3.PEDS11316.
  53. Takahashi K., Nishihara H., Katoh M. et al. A case of atypical teratoid/rhabdoid tumor in an adult, with long survival. Brain Tumor Pathol 2011; 28: 71-76. doi: 10.1007/s10014-010-0008-y.
  54. Takei H., Adesina A.M., Mehta V. et al. Atypical teratoid/rhabdoid tumor of the pineal region in an adult. J Neurosurg 2010; 113: 374-379.
  55. Trembath D., Miller C.R., Perry A. Gray zones in brain tumor classification evolving concepts. Adv Anat Pathol 2008; 15: 5: 287-297.
  56. Torres L.F., Grant N., Harding B.N., Scaravilli F. Intracerebral neuroblastoma. Report of a case with neuronal maturation and long survival. Acta Neuropathol 1985; 68: 2: 110-114.
  57. Tsien C., Moughan J., Michalski J. M. et al. Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group trial 98-03. Int J Radiat Oncol Biol Phys 2009; 73: 3: 699-708. doi: 10.1016/j.ijrobp.2008.05.034.
  58. Utsuki S., Oka H., Tanaka S. et al. Importance of re-examination for medulloblastoma and atypical teratoid/rhabdoid tumor. Acta Neurochir 2003; 145: 663-666. doi: 10.1007/s00701-003-0078-2.
  59. Warmuth-Metz M., Bison B., Dannemann-Stern E. et al. CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system. Neuroradiology 2008; 50: 447-452. doi: 10.1007/s00234-008-0369-7.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.